Real-World Outcomes of Health-Related Quality-of-Life(HRQoL) In Advanced Non-small Cell Lung Cancer Patients Treated with Aumolertinib

被引：0
|
作者：
Li, J. [1 ]
Li, H. [2 ]
Zhao, W. [1 ]
Zhang, Y. [1 ]
Wang, J. [1 ]
Yi, C. [1 ]
Wang, X. [1 ]
Liu, L. [1 ]
机构：
[1] Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Jinan, Peoples R China
[2] Shandong Univ, Sch Pharmaceut Sci, Jinan, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
HRQoL; Aumolertinib; Advanced NSCLC;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP12.01-44
引用
收藏
页码：S658 / S659
页数：2
相关论文
共 50 条
  • [31] Real-World Analysis of Nivolumab and Atezolizumab Efficacy in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer
    Alonso-Garcia, Miriam
    Sanchez-Gastaldo, Amparo
    Munoz-Fuentes, Miguel A.
    Molina-Pinelo, Sonia
    Boyero, Laura
    Benedetti, Johana Cristina
    Bernabe-Caro, Reyes
    PHARMACEUTICALS, 2022, 15 (05)
  • [32] Long-term survival and health-related quality of life with nivolumab for previously-treated advanced non-small cell lung cancer (NSCLC): A wide prospective French real-world study (EVIDENS)
    Barlesi, F.
    Dixmier, A.
    Debieuvre, D.
    Raspaud, C.
    Auliac, J. B.
    Nicolas, B.
    Bombaron, P.
    Moro-Sibilot, D.
    Audigier-Valette, C.
    Asselain, B.
    Dumanoir, J.
    Cotte, F-E.
    Allan, V.
    Calvet, C.
    Reynaud, D.
    Perol, M.
    ANNALS OF ONCOLOGY, 2021, 32 : S1026 - S1026
  • [33] Contemporary real-world radiotherapy outcomes of unresected locally advanced non-small cell lung cancer
    Gouran-Savadkoohi, Mohammad
    Mesci, Aruz
    Pond, Gregory R.
    Swaminath, Anand
    Quan, Kimmen
    Wright, Jim
    Tsakiridis, Theodoros
    JOURNAL OF THORACIC DISEASE, 2023, 15 (02) : 423 - +
  • [34] Real-world Afatinib Outcomes in Advanced Non-small Cell Lung Cancer Harboring EGFR Mutations
    Chen, Chi-Han
    Chang, John Wen-Cheng
    Chang, Ching-Fu
    Huang, Chen-Yang
    Yang, Cheng-Ta
    Kuo, Chih-Hsi Scott
    Fang, Yueh-Fu
    Hsu, Ping-Chih
    Wu, Chiao-En
    ANTICANCER RESEARCH, 2022, 42 (04) : 2145 - 2157
  • [35] HEALTH-RELATED QUALITY-OF-LIFE (HRQOL) IN PATIENTS WITH CHRONIC WOUNDS
    PRICE, PE
    HARDING, KG
    QUALITY OF LIFE RESEARCH, 1994, 3 (01) : 90 - 90
  • [36] Real-world outcomes in patients with unresected stage III non-small cell lung cancer
    Kellie J. Ryan
    Karen E. Skinner
    Ancilla W. Fernandes
    Rajeshwari S. Punekar
    Melissa Pavilack
    Mark S. Walker
    Noam A. VanderWalde
    Medical Oncology, 2019, 36
  • [37] Real-world outcomes in patients with unresected stage III non-small cell lung cancer
    Ryan, Kellie J.
    Skinner, Karen E.
    Fernandes, Ancilla W.
    Punekar, Rajeshwari S.
    Pavilack, Melissa
    Walker, Mark S.
    VanderWalde, Noam A.
    MEDICAL ONCOLOGY, 2019, 36 (03)
  • [38] Real-world outcomes for metastatic non-small cell lung cancer patients treated with checkpoint inhibitor immunotherapy in Canada
    Yusuf, Dimas
    Ko, Jenny J.
    Cho, Hyokeun
    Sheremeto, Corey
    Wang, Ying
    Juergens, Rosalyn A.
    Ellis, Peter Michael
    Billawala, Alkarim
    Kay, Amin
    Kulkarni, Swati
    Elfiki, Tarek A.
    Gupta, Rasna
    Naccarato, Krista
    Pennetti, Alex
    Patel, Devalben
    Smith, Elliot Charles
    Walton, Ryan
    Hurry, Manjusha
    Liu, Geoffrey
    Cheung, Winson Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (05)
  • [39] Real-World Outcomes for Advanced Non-Small Cell Lung Cancer Patients Treated With a PD-L1 Inhibitor Beyond Progression
    Stinchcombe, Thomas E.
    Miksad, Rebecca A.
    Gossai, Anala
    Griffith, Sandra D.
    Torres, Aracelis Z.
    CLINICAL LUNG CANCER, 2020, 21 (05) : 389 - +
  • [40] Evaluation of health-related quality of life and symptoms in patients with advanced non-squamous non-small cell lung cancer treated with nivolumab or docetaxel in CheckMate 057
    Reck, Martin
    Brahmer, Julie
    Bennett, Bryan
    Taylor, Fiona
    Penrod, John R.
    DeRosa, Michael
    Dastani, Homa
    Spigel, David R.
    Gralla, Richard J.
    EUROPEAN JOURNAL OF CANCER, 2018, 102 : 23 - 30
12345